Category Archives: Patent Reform Legislation

Innovation Act Stalls in the House

Posted on July 17, 2015 by Warren Woessner

Representative Goodlatte’s Innovation Act (H.R. 9) has been shelved for now, and will not receive a floor vote until September at the earlier. There is significant conflict between measures intended to deter patent trolls and the ability of non-profit institutional … Continue reading →

Posted in Patent Reform Legislation | Tagged Goodlatte, H.R. 9, intellectual property, IPO, Patent Law, patents, Warren Woessner | 1 Comment

Universities Response to Patent “Reform” Legislation

Posted on February 27, 2015 by Warren Woessner

On February 24th, a letter sent by the Association of American Universities, signed by 145 universities, to Senators Grassley and Leahy and Representatives Goodlatte and Conyers, objected to parts of legislation such as “The Innovation Act, H.R. 9” that purports … Continue reading →

Posted in Patent Reform Legislation | Tagged Association of American Universities, biotechnology, biotechnology law, intellectual property, ip, Patent Law, patent reform, patents | 1 Comment

USPTO Publishes Extensive Examination Guidelines for 35 U.S.C. 102 and 103

Posted on February 14, 2013 by Warren Woessner

On February 14, 2013, the PTO published extensive Examination Guidelines for examination of applications filed after March 16, 2013, under 102 and 103 as amended by the AIA. Given the debates, if not confusion, that arose following the publication of … Continue reading →

Posted in AIA Patent Reform, USPTO Practice and Policy | Tagged AIA, intellectual property, Patent Law, USPTO, Warren Woessner | 2 Comments

USPTO Publishes Rule Package on AIA Administrative Trials

Posted on August 14, 2012 by Warren Woessner

While this is primarily a biotechnology patent law blog, the USPTO’s high level of rule making activity deserves attention, as it will affect us all after the September 16th deadline for implementing many of the new features of the AIA … Continue reading →